Maintenance treatment with capecitabine and bevacizumab versus observation after induction treatment with chemotherapy and bevacizumab in metastatic colorectal cancer (mCRC): The phase III CAIRO3 study of the Dutch Colorectal Cancer Group (DCCG).
暂无分享,去创建一个
O. Dalesio | C. Punt | M. Koopman | F. Erdkamp | P. Nieboer | L. Simkens | H. Tinteren | G. Creemers | A. Cats | R. Jansen | J. J. M. Hoeven | J. Haasjes | F. E. Jongh | J. Braun | Z. Erjavec | L. Mol | O. Loosveld | J. Wals | A. Tije | A. M. E. V. D. Torren | Olaf Loosveld | Jürgen Braun